Ali Ramezani
Impact in
- Nephrology top 5%
- Dialysis and Renal Disease Management
- Virology top 5%
Papers in
- Co-authors
- Robert G. Hawley (23 shared papers)Teresa S. Hawley (9 shared papers)Manuel Velasquez (1 shared paper)Dominic Raj (1 shared paper)Dominic S. Raj (6 shared papers)Björn K.I. Meijers (1 shared paper)Raymond Camille Vanholder (1 shared paper)Pieter Evenepoel (1 shared paper)
- Journals
- Molecular Therapy (4 papers)Stem Cells (3 papers)Gene Therapy (2 papers)Frontiers in bioscience (2 papers)Kidney International (2 papers)
- Partner nations
- United StatesIranCanada
In The Last Decade
Ali Ramezani
50 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 121
- Nephrology 202
- Virology 117
- Genetics 641
- Molecular Biology 1.6k
- Biological Psychiatry 45
Countries citing papers authored by Ali Ramezani
This map shows the geographic impact of Ali Ramezani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Ramezani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Ramezani more than expected).
Fields of papers citing papers by Ali Ramezani
This network shows the impact of papers produced by Ali Ramezani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Ramezani. The network helps show where Ali Ramezani may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Ramezani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 426 | |
| 2 | 2015 | 331 | |
| 3 | 2003 | 255 | |
| 4 | 2003 | 129 | |
| 5 | 2007 | 126 | |
| 6 | 2015 | 91 | |
| 7 | 2018 | 80 | |
| 8 | 2001 | 76 | |
| 9 | 2018 | 75 | |
| 10 | 2014 | 63 | |
| 11 | 2008 | 58 | |
| 12 | 2017 | 54 | |
| 13 | 2001 | 51 | |
| 14 | 2024 | 44 | |
| 15 | 2005 | 41 | |
| 16 | 1993 | 40 | |
| 17 | 2006 | 37 | |
| 18 | 2010 | 36 | |
| 19 | 2002 | 33 | |
| 20 | 2003 | 26 |
About Ali Ramezani
Ali Ramezani is a scholar working on Virology, Genetics, Molecular Biology, Hematology and Oncology, having authored 52 papers that have together received 2.4k indexed citations. Recurring topics across this work include Virus-based gene therapy research (21 papers), CRISPR and Genetic Engineering (15 papers), RNA Interference and Gene Delivery (10 papers), HIV Research and Treatment (9 papers), CAR-T cell therapy research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), RNA and protein synthesis mechanisms (3 papers) and Gut microbiota and health (3 papers). The work is most often cited by research in Nephrology (202 citations), Virology (117 citations), Genetics (641 citations), Molecular Biology (1.6k citations) and Biological Psychiatry (45 citations). Ali Ramezani has collaborated with scholars based in United States, Iran and Canada. Frequent co-authors include Robert G. Hawley, Teresa S. Hawley, Manuel Velasquez, Dominic Raj, Dominic S. Raj, Björn K.I. Meijers, Raymond Camille Vanholder, Pieter Evenepoel, Ziad A. Massy and James Alexander Thomson. Their work appears in journals such as Molecular Therapy, Stem Cells, Gene Therapy, Frontiers in bioscience and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.